Canagliflozin provides durable glycemic improvements and body weight reduction over 104 weeks versus glimepiride in patients with type 2 diabetes on metformin: A randomized, double-blind, phase 3 study - Leiter, L A; Yoon, K H; Arias, P (Diabetes Care, 2015)
et al.